EE200100426A - cPLA2 kristallistruktuur ning agonistide ja antagonistide identifitseerimise meetodid seda kristallistruktuuri kasutades - Google Patents

cPLA2 kristallistruktuur ning agonistide ja antagonistide identifitseerimise meetodid seda kristallistruktuuri kasutades

Info

Publication number
EE200100426A
EE200100426A EEP200100426A EEP200100426A EE200100426A EE 200100426 A EE200100426 A EE 200100426A EE P200100426 A EEP200100426 A EE P200100426A EE P200100426 A EEP200100426 A EE P200100426A EE 200100426 A EE200100426 A EE 200100426A
Authority
EE
Estonia
Prior art keywords
crystal structure
cpla2
antagonists
methods
identifying agonists
Prior art date
Application number
EEP200100426A
Other languages
English (en)
Estonian (et)
Inventor
Dessen Andrea
S. Somers William
L. Stahl Mark
S. Seehra Jasbir
Original Assignee
Genetics Institute, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute, Inc. filed Critical Genetics Institute, Inc.
Publication of EE200100426A publication Critical patent/EE200100426A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EEP200100426A 1999-02-15 2000-02-14 cPLA2 kristallistruktuur ning agonistide ja antagonistide identifitseerimise meetodid seda kristallistruktuuri kasutades EE200100426A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/250,083 US6801860B1 (en) 1999-02-15 1999-02-15 Crystal structure of cPLA2 and methods of identifying agonists and antagonists using same
PCT/US2000/003745 WO2000047763A1 (en) 1999-02-15 2000-02-14 CRYSTAL STRUCTURE OF cPLA2, AND METHODS OF IDENTIFYING AGONISTS AND ANTAGONISTS USING SAME

Publications (1)

Publication Number Publication Date
EE200100426A true EE200100426A (et) 2002-12-16

Family

ID=22946256

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100426A EE200100426A (et) 1999-02-15 2000-02-14 cPLA2 kristallistruktuur ning agonistide ja antagonistide identifitseerimise meetodid seda kristallistruktuuri kasutades

Country Status (23)

Country Link
US (1) US6801860B1 (ru)
EP (1) EP1155144A4 (ru)
JP (1) JP2002540766A (ru)
KR (1) KR20010103010A (ru)
CN (1) CN1238520C (ru)
AU (1) AU779488B2 (ru)
BG (1) BG105886A (ru)
BR (1) BR0008231A (ru)
CA (1) CA2362612A1 (ru)
CZ (1) CZ20012933A3 (ru)
EA (1) EA200100899A1 (ru)
EE (1) EE200100426A (ru)
HK (1) HK1040745A1 (ru)
HR (1) HRP20010678A2 (ru)
HU (1) HUP0200554A3 (ru)
IL (1) IL144673A0 (ru)
MX (1) MXPA01008192A (ru)
NO (1) NO20013947L (ru)
NZ (1) NZ514176A (ru)
PL (1) PL351242A1 (ru)
SK (1) SK11782001A3 (ru)
TR (1) TR200102366T2 (ru)
WO (1) WO2000047763A1 (ru)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001286931A1 (en) 2000-08-30 2002-03-13 The Salk Institute For Biological Studies Methods and compositions for determining isomerase enzymatic activity
EP1329511A4 (en) * 2000-09-19 2005-01-19 Kyowa Hakko Kogyo Kk POLYPEPTIDE WITH PHOSPHOLIPASE A2 ACTIVITY
CA2427352C (en) * 2000-11-07 2010-10-12 I.R.B. Istituto Di Ricerche Biotecnologiche S.R.L. Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase
CA2439182C (en) * 2001-02-22 2009-04-14 Japan Science And Technology Corporation Novel calcium-independent phospholipases a2, genes thereof and promoter of the same
US7718198B2 (en) * 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
US8206753B2 (en) 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7815944B2 (en) * 2001-06-20 2010-10-19 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity
US8142819B2 (en) * 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US7270835B2 (en) * 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US7205151B2 (en) * 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US7901714B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US7901713B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
MXPA05004288A (es) * 2002-10-21 2005-08-02 Metaproteomics Llc Composiciones para tratar o inhibir los estados patologicos asociados con la respuesta inflamatoria.
ATE421357T1 (de) * 2003-05-22 2009-02-15 Metaproteomics Llc Entzündungshemmende arzneizubereitungen zur entzündungsverminderung und die therapie oder die prophylaxe von der gastrischen toxizität
US20050192356A1 (en) * 2004-02-27 2005-09-01 Babish John G. Synergistic anti-inflammatory pharmaceutical compositions and methods of use
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
US20090274778A1 (en) * 2004-11-13 2009-11-05 Babish John G Compositions Exhibiting Inhibition Of Cyclooxygenase-2
US7931904B2 (en) 2005-02-15 2011-04-26 Dana Farber Cancer Institute, Inc. Modulation of MUC1 activity
JP2009504657A (ja) * 2005-08-09 2009-02-05 メタプロテオミクス，エルエルシー ホップ及びアカシア産物によるプロテインキナーゼ調節
US8017315B2 (en) 2005-08-22 2011-09-13 Dana Farber Cancer Institute, Inc. Mitochondrial localization of MUC1
WO2007067812A2 (en) * 2005-12-09 2007-06-14 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
CA2654964A1 (en) * 2006-06-20 2007-12-27 Metaproteomics, Llc Reduced isoalpha acid based protein kinase modulation cancer treatment
WO2008097840A2 (en) 2007-02-02 2008-08-14 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of muc1 by hsf1 and stat3
WO2008097844A2 (en) 2007-02-02 2008-08-14 Dana -Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of apoptosis by muc1 and bh3- containing proapoptotic proteins
WO2008101121A2 (en) 2007-02-14 2008-08-21 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to promoter regulation by muc1 and klf proteins
US8815306B2 (en) * 2007-03-19 2014-08-26 Metaproteomics, Llc Methods and compositions for promoting bone and joint health
JP2010526882A (ja) * 2007-05-11 2010-08-05 メタプロテオミクス， エルエルシー 重金属無害化のための方法と組成物
JP2011506464A (ja) * 2007-12-10 2011-03-03 メタプロテオミクス， エルエルシー 癌、血管新生及びそれらに関連する炎症経路の置換１，３−シクロペンタジオン多重標的プロテインキナーゼ・モジュレーター
WO2009124176A1 (en) * 2008-04-02 2009-10-08 Metaprotemics, Llc Substituted 1,3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions
NZ592537A (en) 2008-10-17 2012-07-27 Dana Farber Cancer Inst Inc Muc-1 cytoplasmic domain peptides as inhibitors of cancer
FI20105629A0 (fi) * 2010-06-03 2010-06-03 Estaja Oy Menetelmä lipidiaktivoituvien entsyymien peptidi-inhibiittoreiden valmistamiseksi ja menetelmällä valmistettuja peptidejä
PL3524618T3 (pl) 2013-03-15 2023-07-10 GLAdiator Biosciences, Inc. Domeny gla jako środki ukierunkowujące
WO2019051002A1 (en) 2017-09-05 2019-03-14 GLAdiator Biosciences, Inc. PROCESS FOR INTRACELLULAR DELIVERY
CN117187211A (zh) * 2023-08-04 2023-12-08 华南理工大学 一种磷脂酶c晶体及磷脂酶c突变体的制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622832A (en) 1990-02-28 1997-04-22 Genetics Institute, Inc. Arachidonic acid releasing phospholipase A2 enzyme and methods of use
CA2061738A1 (en) * 1991-03-01 1992-09-02 Ruth M. Kramer Antibodies reactive with human cytosolic phospholipase a2
IL101507A0 (en) 1991-04-17 1992-12-30 Lilly Co Eli Compounds,vectors and methods for expressing human,cytosolic phospholipase a2
US5221410A (en) 1991-10-09 1993-06-22 Schering Corporation Crystal forming device
US5466595A (en) 1994-07-27 1995-11-14 Genetics Institute, Inc. Calcium independent cytosolic phospholipase A2/B enzymes

Also Published As

Publication number Publication date
HUP0200554A3 (en) 2006-06-28
EP1155144A4 (en) 2002-08-28
TR200102366T2 (tr) 2002-02-21
NZ514176A (en) 2004-09-24
PL351242A1 (en) 2003-04-07
NO20013947D0 (no) 2001-08-14
AU779488B2 (en) 2005-01-27
CZ20012933A3 (cs) 2002-02-13
JP2002540766A (ja) 2002-12-03
AU2993700A (en) 2000-08-29
EA200100899A1 (ru) 2002-04-25
IL144673A0 (en) 2002-05-23
BR0008231A (pt) 2001-10-30
CN1348502A (zh) 2002-05-08
BG105886A (en) 2002-05-31
MXPA01008192A (es) 2002-10-23
SK11782001A3 (sk) 2002-03-05
NO20013947L (no) 2001-10-10
KR20010103010A (ko) 2001-11-17
CA2362612A1 (en) 2000-08-17
HK1040745A1 (zh) 2002-06-21
HRP20010678A2 (en) 2003-08-31
HUP0200554A2 (en) 2002-06-29
US6801860B1 (en) 2004-10-05
WO2000047763A1 (en) 2000-08-17
CN1238520C (zh) 2006-01-25
EP1155144A1 (en) 2001-11-21

Similar Documents

Publication Publication Date Title
EE200100426A (et) cPLA2 kristallistruktuur ning agonistide ja antagonistide identifitseerimise meetodid seda kristallistruktuuri kasutades
BR0016661B1 (pt) Métodos para formação de um dispositivo eletrônico, dispositivo eletrônico e dispositivo de exibição
ID30401A (id) Turunan-turunan indol dan penggunaannya sebagai antagonis mcp-1
EE200100243A (et) 5HT1 retseptori agonistid ja metoklopramiid migreeni raviks
GB2345753B (en) Optical probe for analysis of formation fluids
PT1189916E (pt) N-pirazole agonistas do receptor a2a
NO20022105L (no) Positive modulatorer av nikotiniske reseptoragonister
EE200100358A (et) Meetod ja komplekt prioonivalgu ekstraheerimiseks
PT1049689E (pt) Compostos de 4-(2-ceto-1-benzimidazolinil)piperidina como agonistas do receptor orl1
DK1206217T3 (da) Engangs testvial med pröveafgivelsesindretning
DE69920395D1 (de) Vorrichtung zur Ortsbestimmung von endokardialen Elektroden
ID30185A (id) Gula-gula dingin dan metode pembuatannya
ID27544A (id) Agonis dan antagonis muskarinat
DE60028368D1 (de) Agonisten des peroxisom aktivator-responsiven rezeptors
NO20022009D0 (no) Positive modulatorer av nikotiniske reseptoragonister
DE69819008D1 (de) Mikroskop zur nachgiebigkeitsmessung
FI990888A0 (fi) Menetelmä ja testikittejä respiratorisen alueen tulehduksen läsnäolon ja vaikeusasteen arvioimiseksi
EP1137938A4 (en) METHODS FOR DETECTION OF HDPXU17 RECEPTOR AGONISTS AND ANTAGONISTS
FI982570A0 (fi) Menetelmä ja laite prosessinesteiden viskoelastisten ominaisuuksien määrittämiseksi ja sen käyttö
ATE305925T1 (de) Positive modulatoren von nicotinrezeptor- agonisten
NO996406D0 (no) Fremgangsmåte for påvisning av orientering av fiberstrukturen
DE60011509D1 (de) Vorrichtung zur Reduzierung der Verzerrung von Fluidlagerflächen
FR2797894B3 (fr) Instrument pour nettoyer rapidement de grandes surfaces
DE69914136D1 (de) Gerät zur Steigerung der Festigkeit von Metallteilen
AU4551499A (en) Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-HT3 receptors